ISRG stock sentiment todayIntuitive Surgical, Inc.
Sentiment verdict
Gossip first, financials second — NEUTRAL at 75% confidence.
Last updated · cached analysis, refreshes periodically
ISRG
Intuitive Surgical, Inc.A dominant market leader facing a 'sell the news' reaction due to sky-high valuation and temporary legal settlement overhang.
Pick a name and you can add your own 1-, 3- and 6-month price calls — no account needed. The needle above shows where the crowd sits. Calls lock 48 hours after you make them, so every scorecard stays honest.
You'll show up on boards and The Floor under this name. Add an email later to keep your history.
No account needed. You can add an email later to keep your calls.
Already have an account? Sign in
See exactly how analyst targets, gossip sentiment and momentum are weighted into this 6-month forecast.
Sign in to go Pro →Full model breakdown (analyst / gossip / momentum weights) is a Pro feature. Modelled for ISRG. Not financial advice.
Price · last 12 months
Gossip
The market is currently punishing ISRG despite an earnings beat. The narrative is dominated by 'elevated buy-side expectations' that the company failed to exceed, coupled with news of a legal settlement that spooked short-term traders. While history suggests long-term rewards, the immediate chatter focuses on whether the stock's premium is still justified.
- ·Da Vinci 5 system rollout momentum
- ·Legal settlement disclosures
- ·Valuation correction after recent peaks
- ·High expectations vs. realized performance
Financial
ISRG maintains a pristine balance sheet with zero debt and a massive cash pile. While revenue growth remains robust (low double digits), the recent drop in profit margins and high P/E (forward P/E ~65x) makes it one of the most expensive stocks in the MedTech space.
- ·Revenue growth: 12-14% YoY
- ·Operating Margin: ~25-30%
- ·Current Ratio: >4.0 (exceptional liquidity)
- ·Recurring revenue (instruments/accessories): >75% of total
Conviction
Whose money is actually in the stock — insider open-market trades and the patience of the institutional holder base.
Strong conviction — insiders and patient capital are backing this.
- ·No open-market insider trades in the last 120 days.
Pro shows every named insider trade in the window (buyer, title, size, price, and whether it was a pre-scheduled 10b5-1 sale) plus the full holder register split into patient capital and fast money.
Unlock with Pro →Source: SEC EDGAR Form 4 + 13F holder register. Option exercises, grants, gifts and tax withholding are excluded — only open-market purchases and sales count. Not financial advice.
Risks
- ·High valuation leaves zero room for execution errors
- ·Increased competition in the soft-tissue robotic space
- ·Hospital capital expenditure cycles slowing down
- ·Short-term margin compression from Da Vinci 5 launch costs
Peer temperature
How direct competitors stack up against ISRG right now.
- NEUTRALMDTMedtronic plc
COLDER — slower growth and legacy baggage, but offers a much safer 3.5% dividend yield and significantly lower P/E for value-conscious investors.
See full analysis → - HOTSYKStryker Corporation
HOTTER — stronger price momentum and dominance in orthopedic robotics (Mako) with more diversified revenue streams across med-surg.
See full analysis → - HOTBSXBoston Scientific
HOTTER — currently outperforming on top-line growth with a more favorable risk-reward profile in the cardiovascular and neuromodulation segments.
See full analysis →
- ISRG+6.2%
- MDT+11.9%
- SYK+6.0%
- BSX-3.8%
Analyst price target
Consensus average of 23 analysts · median 500.00
Source: StockAnalysis.com · updated 2026-10-21
Recent headlines
- Yahoo FinanceIntuitive Surgical, Inc. (ISRG) Stock Forecasts
- TrefisIs Intuitive Surgical Stock’s Market Price Justified?
- Investor's Business DailyIntuitive Surgical Hammered As Elevated Buy-Side Views Outshine Solid Numbers
- TradingViewIntuitive Surgical vs. Boston Scientific: Which Stock Is a Better Buy Now?
- Simply Wall StHow Revenue Growth And Profit Decline Will Impact Intuitive Surgical Stock
- GuruFocusIs Intuitive Surgical Inc (ISRG) a Bargain After 3.7% Drop? GF V
AI-generated analysis for informational purposes only. Not financial advice.